Please see below to view the coverage details for this session entry.

Wednesday, October 24


Survivorship Research: Moving from Risk to Risk Reduction

In the past two decades, much has been learned about the risk of long-term and late effects following curative cancer therapy. Two serious outcomes which contribute to the burden of morbidity and lead to premature death of a cancer survivor are cardiovascular disease and subsequent malignant neoplasms. These outcomes may be secondary to the cancer therapy, genetic factors, unhealthy lifestyle behaviors, comorbid health conditions, or an interaction between any of these factors. While the very young and the elderly are particularly susceptible, all ages are adversely affected. This session will describe the long-term mortality and serious morbidity in cancer survivors. Using subsequent malignant neoplasms and cardiovascular disease as paradigms, methods to move from understanding risk to reducing risk will be discussed.

Wednesday October 24, 2012 2:15pm - 3:00pm
Sabine (9721 Arboretum Boulevard, Austin, TX 78759)

Kevin C. Oeffinger, MD

Director, Adult Long-Term Follow-up Program, Memorial Sloan-Kettering Cancer Center